New substituted pyrazolones and dipyrazolotriazines as promising tyrosyl-tRNA synthetase and peroxiredoxin-5 inhibitors: Design, synthesis, molecular docking and structure-activity relationship (SAR) analysis

New substituted pyrazolone and dipyrazolotriazine derivatives have been synthesized, designed and well characterized as promising dual antimicrobial/antioxidant agents to overcome multidrug resistant bacteria (MDR), oxidative stress and their related diseases. Among all strains, S. aureus was found to be the most susceptible for all compounds except 10b and 12b. Out of the three investigated series, sulfonamide analogues 5a-c displayed excellent antibacterial activity with 5b (MIC = 7.61 ?M) and 5a (MIC = 8.98 ?M) displaying activity that exceeds the reference drug tetracycline (MIC = 11.77 ?M). The same sulfonamide derivatives 5a-c demonstrates high ABTS scavenging capacity comparable to standard. Moreover, the structure-activity relationship (SAR) revealed that benzenesulfonamide is a crucial group for enhancing activity. Molecular docking studies of the potent analogues were performed by targeting the crystal structures of S. aureus tyrosyl-tRNA synthetase and human peroxiredoxin-5 enzymes and the obtained results supported well the in vitro data revealing stronger binding interactions. Pharmacokinetics prediction together with modeling outcomes suggests that our sulfonamide derivatives may serve as useful lead compounds for the treatment of infectious disease.

Automated summary

Novel substituted pyrazolone and dipyrazolotriazine derivatives were synthesized and characterized as potential dual antimicrobial/antioxidant agents. The sulfonamide analogues demonstrated excellent antibacterial activity and ABTS scavenging capacity, with SAR revealing benzenesulfonamide as a crucial group for enhancing activity. Molecular docking studies confirmed stronger binding interactions of the potent analogues with target enzymes, suggesting potential as lead compounds for infectious disease treatment.